Complex Regulation of Membrane-Type Matrix Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation by Concanavalin A in MDA-MB-231 Human Breast Cancer Cells

Cancer Research

Volumn 55, Issue 15, 1995, Pages 3272-3277

  Yu, Ming ^a,b   Sato, Hiroshi ^c   Seiki, Motoham ^c   Thompson, Erik W ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GELATINASE; METALLOPROTEINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CONCANAVALIN A; CYCLOHEXIMIDE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GELATINASE A; GELATINASES; HUMAN; METALLOENDOPEPTIDASES; PROTEIN PRECURSORS; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0029099036     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Terranova, V. P., Hujanen, E. S., and Martin, G. R. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst., 77: 311–316, 1986.
2. Murphy, G., Reynolds, J. J., and Hembry, R. M. Metalloproteinases and cancer invasion and metastasis. Int. J. Cancer, 44: 757–760, 1989.
3. Stetler-Stevenson, W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metast. Rev., 9: 289–303, 1990.
4. Albini, A., Melchiori, A., Santi, L., Liotta, L. A., Brown, P. D., and Stetler-Stevenson, W. G. Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst., 83: 775–779, 1991.
5. Hoyhtya, M., Hujanen, E., Turpeenniemi-Hujanen, T., Thorgiersson, U. P., Liotta, L. A., and Trygvason, K. Modulation of type IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type IV collagenase. Int. J. Cancer, 46: 282–286, 1990.
6. Tryggvason, K. Type IV collagenase in invasive tumors. Breast Cancer Res. Treat., 24: 209–218, 1993.
7. Hoyhtya, M., Fridman, R., Komarek, D., Perter-Jordan, K., Stetler-Stevenson, W. G., Liotta, L. A., and Liang, C. M. Immunohistochemical localization of matrix metal-loproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int. J. Cancer, 56: 500–505, 1994.
8. Polette, M., Gavel, C., Cockett, M., Girod de Bentzmann, S., Murphy, G., and Birembaut, P. Detection and localization of mRNA's encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion & Metastasis, 13: 31–37, 1993.
9. Davies, B., Miles, D. W., Hepperfield, L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D., and Balkwill, F. R. Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer, 67: 1126–1131, 1993.
10. Emonard, H. P., Remade, A. G., Noel, A. C., Grimaud, J-A., Stetler-Stevenson, W. G., and Foidart, J-M. Tumor cell surface-associated binding site for the MT 72,000 type IV collagenase. Cancer Res., 52: 5845–5848, 1992.
11. Monsky, W. L., Kelly, T., Un, C-Y., Yeh, Y., Stetler-Stevenson, W. G., Mueller, S. C., and Chen, W-T. Binding and localization of MT 72,000 matrix metalloprotein-ase at cell surface invadopodia. Cancer Res., 53: 3159–3164, 1993.
12. Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Shima, T. B., Torn, J., Donahue, S., Lippman, M. E., Martin, G. R., and Dickson, R. B. Association of increased basement membrane-invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol., 150: 534–544, 1992.
13. Azzam, H. S., and Thompson, E. W. Collagen-induced activation of the Mt 72,000 type IV collagenase in normal and malignant human fibroblast cells. Cancer Res., 52: 4540–4544, 1992.
14. Azzam, H. S., Arand, G. A., Lippman, M. E., and Thompson, E. W. MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. J. Natl. Cancer Inst., 85: 1758–1764, 1993.
15. Maiti, S. N., Yu, M., Bueno, J., Tirgari, R. H., Palao-Marco, F. L., Pulyaeva, H., and Thompson, E. W. Differential regulation of matrix metalloproteinase-2 (MMP-2) activation in human breast cancer cell lines. Ann. NY Acad. Sci., 732: 456–459, 1994.
16. Strongin, A. Y., Manner, B. L., Grant, G. A., and Goldberg, G. I. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268: 14033–14039, 1993.
17. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370: 61–65, 1994.
18. Takino, T., Sato, H., Yamamoto, E., and Seiki, M. Coning of a gene potentially encoding a novel matrix metalloproteinase having a fra/u-membrane domain at the C terminus. Gene, 755: 293–298, 1995.
19. Strongin, A. Y., Collier, I. E., Bannikov, G. A., Manner, B. L., Grant, G. A., and Goldberg, G. I. Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J. Biol. Chem., 270: 5331–5338, 1995.
20. Cao, J., Sato, H., Takino, T., and Seiki, M. The C-terminal region of membrane type matrix metalloproteinase (MT-MMP) is a functional transmembrane domain reguired for pro-gelatinase activation. J. Biol. Chem., 270: 801–805, 1995.